Skip to main content
. 2006 Jul 19;2006(3):CD001257. doi: 10.1002/14651858.CD001257.pub2

Murck 2001.

Trial name or title A multicentre, double‐blind, randomised, parallel group, placebo‐controlled, dose‐ranging pilot study of ethyl‐eicosapentaenoate (ethyl‐EPA) in patients with schizophrenia.
Methods Allocation: randomised. 
 Blindness: double.
Participants Diagnosis: schizophrenia.
Interventions 1. Varied doses of E‐EPA. 
 2. Placebo.
Outcomes  
Starting date  
Contact information  
Notes